GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hansoh Pharmaceutical Group Co Ltd (HKSE:03692) » Definitions » Price-to-Operating-Cash-Flow

Hansoh Pharmaceutical Group Co (HKSE:03692) Price-to-Operating-Cash-Flow : 43.36 (As of Apr. 25, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Hansoh Pharmaceutical Group Co Price-to-Operating-Cash-Flow?

As of today (2024-04-25), Hansoh Pharmaceutical Group Co's share price is HK$17.04. Hansoh Pharmaceutical Group Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 was HK$0.39. Hence, Hansoh Pharmaceutical Group Co's Price-to-Operating-Cash-Flow Ratio for today is 43.36.

The historical rank and industry rank for Hansoh Pharmaceutical Group Co's Price-to-Operating-Cash-Flow or its related term are showing as below:

HKSE:03692' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 18.64   Med: 37.76   Max: 94.29
Current: 43.35

During the past 8 years, Hansoh Pharmaceutical Group Co's highest Price-to-Operating-Cash-Flow Ratio was 94.29. The lowest was 18.64. And the median was 37.76.

HKSE:03692's Price-to-Operating-Cash-Flow is ranked worse than
81.71% of 678 companies
in the Drug Manufacturers industry
Industry Median: 17.32 vs HKSE:03692: 43.35

Hansoh Pharmaceutical Group Co's Cash Flow from Operations per share for the six months ended in Jun. 2023 was HK$0.21. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 was HK$0.39.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Hansoh Pharmaceutical Group Co was -40.10% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -8.60% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 9.70% per year.

During the past 8 years, Hansoh Pharmaceutical Group Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 40.30% per year. The lowest was -8.60% per year. And the median was 13.35% per year.


Hansoh Pharmaceutical Group Co Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Hansoh Pharmaceutical Group Co's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hansoh Pharmaceutical Group Co Price-to-Operating-Cash-Flow Chart

Hansoh Pharmaceutical Group Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial 38.31 77.28 36.12 28.76 -

Hansoh Pharmaceutical Group Co Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 36.12 - 28.76 - -

Competitive Comparison of Hansoh Pharmaceutical Group Co's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Hansoh Pharmaceutical Group Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hansoh Pharmaceutical Group Co's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hansoh Pharmaceutical Group Co's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Hansoh Pharmaceutical Group Co's Price-to-Operating-Cash-Flow falls into.



Hansoh Pharmaceutical Group Co Price-to-Operating-Cash-Flow Calculation

Hansoh Pharmaceutical Group Co's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=17.04/0.393
=43.36

Hansoh Pharmaceutical Group Co's Share Price of today is HK$17.04.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Hansoh Pharmaceutical Group Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 was HK$0.39.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Hansoh Pharmaceutical Group Co Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Hansoh Pharmaceutical Group Co's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Hansoh Pharmaceutical Group Co (HKSE:03692) Business Description

Traded in Other Exchanges
Address
287 Xiangke Road, Pudong New District, Shanghai, CHN, 201210
Hansoh Pharmaceutical Group Co Ltd is a research and development-driven pharmaceutical company in China. The company holds a broad, diversified drug portfolio in CNS diseases, oncology, anti-infectives, and diabetes. Further, it also focuses on metabolic diseases and anti-tumor. The majority of revenue is generated from the sale of pharmaceutical products in Mainland China.

Hansoh Pharmaceutical Group Co (HKSE:03692) Headlines

No Headlines